Economic Daily-China Economic Network, December 3rd. The "Second Forum on Responsible Medicine Entrepreneur Responsibility and the Quality of Traditional Chinese Medicine" sponsored by China Economic Network, jointly sponsored by China Association of Chinese Medicine and the National Chamber of Commerce of Industry and Commerce Dialogue with Development ", held in Beijing on November 28. This activity was guided by the State Drug Administration and is one of the key activities in the "National Drug Safety Month" series, with the theme "Innovation and Drug Safety".
Standing member of the Standing Committee of the Twelfth National People's Congress, Deputy Chairman of the Foreign Affairs Committee of the National People's Congress, Chairman of the China Overseas Talent Development Foundation, Cao Weizhou, and relevant leaders of the Ministry of Industry and Information Technology, the State Drug Administration and the State Administration of Traditional Chinese Medicine attended the meeting. Nearly 200 people, including representatives of companies in the pharmaceutical-related field, industry associations, and hospital representatives, discussed in depth how to further stimulate the vitality of enterprise innovation and how to deal with the safety brought by innovative drugs in the context of the continuous optimization of national innovation policies and the environment. challenge.
To implement a healthy China strategy, we must always focus on the goal of improving people's health, persist in using reforms and development ideas and methods, resolve outstanding contradictions, and safeguard and develop people's health rights and interests. Cao Weizhou suggested that we must unswervingly deepen the reform of the medical and health system, give full play to the role of science and technology and talents, and promote communication and collaboration among various departments and industries. He said that the Healthy China Strategy is a national strategy to comprehensively improve the health of the Chinese nation and achieve coordinated development of people's health and the economy and society. It is a comprehensive strategy that includes economic, social, cultural, and ecological aspects. It must be widely mobilized from all sectors of society. Motivation and creativity, to promote communication and collaboration between various departments and industries, to form a strong joint force to maintain and promote health, and to promote the modernization of the governance system and governance capabilities in the medical field.
The TCM industry chain is long and involves many links. Each link is related to the quality of the drug. How to ensure quality and safety? Sun Liying, inspector of the Department of Science and Technology of the State Administration of Traditional Chinese Medicine, said that it must be grasped from the height of the entire industrial chain, starting from the source of Chinese medicinal materials, ensuring the quality and safety of each medicinal material, ensuring product quality and safety and effectiveness, thereby ensuring clinical Safety and efficacy. She said that traditional Chinese medicine should follow the rules of traditional Chinese medicine in terms of product development, production, and clinical aspects. At the same time, its connotation must be interpreted with modern science and technology. It is necessary to adopt modern technology to enhance market competitiveness and maintain high-quality and high-efficiency development in inherited innovation.
Ji Yanfeng, vice chairman of the National Chamber of Commerce for Medicine and Commerce, also said that the quality control of the source of Chinese medicinal materials should be effectively implemented, and illegal activities involving Chinese medicinal materials should be supervised and reported. The illegal enterprises should be included in the blacklist of the pharmaceutical industry. Companies actively participate in the formulation of national standards, vigorously promote authentic medicinal products, and promote the healthy development of the traditional Chinese medicine industry.
In the view of Shen Nuo, the deputy secretary general of the Chinese Medicine Association of China, Chinese medicine companies are an important force in the development of the Chinese medicine industry. To build Chinese medicine products and brands with excellent quality, reputation and efficacy, entrepreneurs are the soul and responsibility of enterprises. Take the initiative to assume the main responsibility for product quality and safe use of medicines.
Wang Xudong, president of China Economic Net, put forward opinions on the development of the Chinese medicine industry from the perspective of the media. First, the entire industry and society must attach great importance to drug safety. Secondly, to ensure the safety of medicines, we should adhere to the "emphasis on production and management", and form a social co-governance pattern in which governments, enterprises, the media, and the public each play their roles. Third, adhere to innovative transformation and innovative development. Fourth, in the construction of the “Belt and Road” initiative, the Chinese medicine industry will be developed through mutual learning between Chinese and foreign cultures.
In the theme report session, Shi Yuankai, deputy director of the National Cancer Center and deputy director of the Cancer Hospital of the Chinese Academy of Medical Sciences, director of the Chinese Academy of Traditional Chinese Medicine, Xiao Xiaohe, director of the Integrated Traditional Chinese and Western Medicine Center of the 32nd Hospital of the Chinese People's Liberation Army, and drug research and development of the Chinese Pharmaceutical Association Member of the professional committee Zhao Yan, Deputy Dean of Howson Pharmaceutical Research Institute, Lian Xiaogang, Senior Vice President of Luye Pharmaceutical Group Xue Yunli, Chen Genghui, General Manager of Beijing Wenfeng Tianji Pharmaceutical Technology Co., Ltd., Song Haibo, Pharmacist, Director of Chinese Medicine Division, National Drug Evaluation Center, Meng Xiangyun, Chief Engineer of Jiuzhitang Group, Pan Qin, Deputy General Manager and Chief Engineer of Hongri Pharmaceutical, and other experts, scholars, and entrepreneurs focus on the theme of the conference, from drug development and innovation, clinical safety evaluation and adverse reaction analysis of traditional Chinese medicine, and new anticancer drugs. Presentations on value and risk.
Last year, 20 pharmaceutical companies issued a declaration on safe drug use at the first Safe Drug Entrepreneur Responsibility Forum hosted by China Economic Net. Among them, 12 companies including Luye Pharmaceutical, Good Doctor Group, Yangzijiang Pharmaceutical Group, Hongri Pharmaceutical, Neck Recon Pharmaceutical, and Shengshi Baicao have adhered to the declaration over the past year and set an example in the industry. In order to encourage more companies to abide by corporate responsibility and improve public drug safety, the forum honored these 12 companies, and Wang Xudong, president of China Economic Net, awarded these enterprises representatives the honorary trophy of “Excellent Social Responsibility in Safe Drug Practice in 2019”.
Integrity and responsibility are the lives of pharmaceutical companies. At this forum, Xue Yunli, senior vice president of Luye Pharmaceuticals, led Howson Pharmaceuticals, Good Doctor Group, Jiuzhitang Group, Yangtze River Pharmaceutical Group, Sinopharm, Yabao Pharmaceutical, Guangzhou Pharmaceutical Group, Hongri Pharmaceutical, Taiji Group, Zhizhi Representatives of 30 companies from various industries including biomedicine, chemical medicine, traditional Chinese medicine, medical equipment and vaccines jointly issued the "2020 Declaration on Innovation and Safe Use of Drugs", in order to promote innovation, ensure public drug safety, and promote the industry We have made a solemn commitment to healthy development.
In response to the public's concern about the quality and safety of traditional Chinese medicine, the event also held a "Traditional Chinese Medicine Quality and Development Dialogue". Former Deputy Secretary-General of the National Pharmacopoeia Committee, Zhou Fucheng, Vice General Manager of Shengshi Baicao, and Gui Tao, Assistant to President of Kangmei Pharmaceutical Zhao Zhongding, deputy general manager of Nanjing Haichang Chinese Medicine, Xu Shuxiang, chairman of the Media Special Committee of the Chinese Medicine Association of China, and other experts and scholars from different fields said that “inheritance is not ancient, innovation is not inseparable”. Promote the high-quality development of Chinese medicine.
As the organizer of this event, China Economic Net carried a live video coverage of the event through the CEI Cloud Live Broadcasting Platform, and produced special topics for publicity, attracting more than 200,000 followers, and was widely discussed by all sectors of society.
In 2007, since the National Drug Administration launched the "National Drug Safety Month" event, it has been held for 12 consecutive sessions, which has played an important role in popularizing the safety knowledge of medicinal equipment and promoting social co-governance. The "National Safe Drug Use Month" in 2019 was launched in mid-October, and various departments and units in various places organized various forms of publicity activities to jointly promote the safety exchange of medicine and machinery and improve the scientific literacy of the public.